Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Lemaitre Vascular Inc chart...

About the Company

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

CEO

George LeMaitre

Exchange

NASDAQ

Website

http://www.lemaitre.com/

$167M

Total Revenue

411

Employees

$1B

Market Capitalization

51.66

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LMAT News

Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular

1d ago, source:

What Happened: LeMaitre, Chairman and CEO at LeMaitre Vascular, exercised stock options for 14,808 shares of LMAT stock. This information was disclosed in a Form 4 filing with the U.S. Securities and ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript

29d ago, source: Hosted on MSN

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript February 27, 2024 LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36.

LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference

2d ago, source:

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April ...

LeMaitre Vascular Inc LMAT

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LeMaitre to Participate at Upcoming Investor Conferences in March

27d ago, source: Nasdaq

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops ...

Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend

21d ago, source: Yahoo Finance

Readers hoping to buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day ...

Q4 2023 LeMaitre Vascular Inc Earnings Call

1mon ago, source: Yahoo Finance

JJ Pellegrino; CFO; LeMaitre Vascular, Inc. George LeMaitre; CEO and Chairman; LeMaitre Vascular, Inc. Dave Roberts; President; LeMaitre Vascular, Inc. Suraj Kalia ...

LMAT LeMaitre Vascular, Inc.

1mon ago, source: Seeking Alpha

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts ...

LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript

29d ago, source: Seeking Alpha

Welcome to the LeMaitre Vascular Q4 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I would like to turn the conference over to Mr. J.J ...

LeMaitre Vascular Inc LMAT

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript

29d ago, source: Insider Monkey

LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end ...

Lemaitre Vascular Inc

7d ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...